Prevalence of viral hepatitis (B and C) serological markers in healthy working population

Rev Esp Enferm Dig. 2013 May-Jun;105(5):249-54. doi: 10.4321/s1130-01082013000500002.

Abstract

Introduction and objectives: prevalence of viral hepatitis (B and C) changes geographically. Our aim was to determinate the prevalence of hepatitis B (HBV) and hepatitis C virus (HCV) serological markers in healthy working population and to describe the epidemiological characteristics associated to its presence.

Methods: blood samples and epidemiological data of 5,017 healthy workers from Murcia and Madrid were recorded prospectively.

Results: a total of 5,017 healthy volunteers participated. Mean age 39 ± 11 years, men predominance (73 %). Prevalence of serological markers of HCV and HBV was 0.6 % and 0.7 %. Age of patients with HCV antibody was significantly higher (43 + or - 9 years vs. 39 + or - 11 years; p = 0.03). We observed significant differences in liver test values (alanine aminotransferase [ALT] 64 ± 56 IU/L vs. 28 ± 20 IU/L; p < 0.001; aspartate aminotransferase [AST] (51 + or - 45 IU/L vs. 23 + or - 12 IU/L; p < 0.001) and in gamma-glutamyltransferase(GGT) value (104 + or - 122 IU/L vs. 37 + or - 46 IU/L; p < 0.001. The presence of HCV antibody was related significantly to previous transfusion (13 % vs. 5 %; p = 0.03), tattoos (29 % vs. 13 %; p < 0.01), intravenous drug addiction (13 % vs. 0.2 %; p < 0.001) and coexistence with people with positive HCV antibody (16 % vs. 4 %; p < 0.001). In HBV no differences in basal characteristics were observed with exception in AST values (29 + or - 15 IU/L vs. 23 + or - 12 IU/L; p < 0.01). Hepatitis B surface antigen (HBsAg) was related significantly to previous transfusion (15 % vs. 5 %; p < 0.01), tattoos (26 % vs. 14 %; p = 0.04) and coexistence with people with positive HBsAg (17 % vs. 4 %; p < 0.001).

Conclusions: Prevalence of serological markers in healthy working population is low. Risk factors for infection were previous transfusion and tattoos. Intravenous drug addiction was only a risk factor in HCV.

MeSH terms

  • Adult
  • Biomarkers / blood
  • Cross-Sectional Studies
  • Female
  • Hepatitis B / blood*
  • Hepatitis B / epidemiology*
  • Hepatitis B Surface Antigens / blood*
  • Hepatitis C / blood*
  • Hepatitis C / epidemiology*
  • Hepatitis C Antibodies / blood*
  • Humans
  • Male
  • Prevalence
  • Prospective Studies
  • Seroepidemiologic Studies

Substances

  • Biomarkers
  • Hepatitis B Surface Antigens
  • Hepatitis C Antibodies